Acciones Cyteir Therapeutics, Inc.
Acciones
CYTT
US23284P1030
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/12/20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/02/22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
Jean George
BRD | Director/Board Member | 66 | 01/04/13 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+1,12 % | 43,84 mil M | |
+6,77 % | 41,68 mil M | |
+45,26 % | 41,25 mil M | |
-11,96 % | 27,04 mil M | |
+6,01 % | 25,53 mil M | |
-24,92 % | 18,18 mil M | |
-3,63 % | 12,29 mil M | |
+27,16 % | 12,29 mil M | |
+7,30 % | 11,15 mil M |